VA
CC icon

Vident Advisory’s Chemours CC Stock Holding History

Vident Advisory’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,377
Closed -$430K – 1423
2024
Q1 		$430K Buy
16,377
+6,913
+73% +$197K 0.01% 881
2023
Q4 		$298K Buy
9,464
+2,249
+31% +$61K 0.01% 1008
2023
Q3 		$202K Buy
+7,215
New +$248K 0.01% 1112

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vident Advisory's CC Position: Q2 2024 in Review

Vident Advisory sold out of Chemours (CC) in Q2 2024, closing a stake of 16,377 shares — an estimated $430K sold.

Vident Advisory first reported a position in CC in Q3 2023 and held it in 3 quarters. The position peaked at $430K in Q1 2024. 437 funds tracked by Wall St. Rank hold CC as of Q2 2024.

  • Vident Advisory reported no remaining Chemours position as of Q2 2024 after selling out during the quarter.
  • Vident Advisory sold 16,377 Chemours shares in Q2 2024, an estimated $430K.
  • Vident Advisory first reported a position in Chemours in Q3 2023 and held it in 3 quarters.
  • Vident Advisory's Chemours position peaked at $430K in Q1 2024.
  • 437 funds tracked by Wall St. Rank held Chemours as of Q2 2024.

Based on Vident Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.